ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
 
AMA Credit Designation Statement: 
The Medical College of Wisconsin designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hours of  Participation for Allied Health Professionals:
The Medical College of Wisconsin designates this activity for up to 1.25 hours of participation for continuing education for allied health professionals. 

Session date: 
Wednesday, July 15, 2020 - 7:30am to 8:45am
Location: 
Medical College of Wisconsin
8701 Watertown Plank Road
A6520, Hub for Collaborative Medicine
Milwaukee, WI 53226
United States
  • 1.25 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.25 Hours of Participation
    Hours of Participation credit.

Please login or register to take this course.
Program Description: 

This educational activity is designed to enhance the knowledge of the academic and community dermatologists who attend our weekly meeting.  Live patients are invited to grand rounds who demonstrate key points in patient diagnosis management and will emphasize application of evidence-based medicine.  Speaker topics will be chosen based on Grand Rounds quarterly evaluations as well as Wisconsin Dermatological Society evaluations where attendees were asked "What clinical questions or patient problems did you encounter in the past year that you felt you needed more knowledge or competence to successfully address?"

Target audience: 
Physician
Physician (fellow/resident)
Physician Assistant
Nurse Practitioner
AP/NP
Learning objectives: 
  • Perform an accurate and thorough skin exam including mucosal surfaces in order to describe morphology and generate a differential diagnosis.
  • Integrate multiple findings on a given patient including history, physical exam, laboratory, exam, histopathologic findings and other information for the purpose of making an accurate diagnosis of inflammatory, neoplastic or genetic skin diseases
  • Evaluate and establish therapeutic recommendations and further diagnostic tests recommendations in light of best medicine guidelines, evidence based medicine, literature review and consensus of expert opinion.
Faculty & credentials: 
Activity Director:
Leah Lalor, MD

Planning Committee:
Yvonne Chiu, MD
Karolyn Wanat, MD
 

All persons in control of content have NO relevant financial relationships to disclosure except:

Name

Company                         

Role                                                 

Leah Lalor, MDUpToDateWriter/Reviewer

Yvonne Chiu, MD

Novan

DSMB Member

Julia Kasprzak, MDCastle BiosciencesPI
Kristen Holland, MD

Abbvie
Pfizer
Sanofi
Celgene
Lilly

Spouse employment
Ad Board
Investigator
Investigator
Investigator

Stephen Humphrey, MDCelgene
Pfizer
Sub-Investigator
Sub-Investigator
Dawn Siegel, MDUptoDate
ArQule
Writer
Consultant
Keri Chaney,MDRegeneronAdvisory Board
Edit Olasz, MD, PhDTopix Pharma
Harken Derm
Speaker
Owner
Kenneth Gordon, MD

Abbvie, BMS, Celgene,
Eli Lilly, Janssen, Novartis

Dermira, Dermanant, Almirall,
Amgen, Leo, Sun, Pfizer,
UCB, Ortho

Consult/Investigator

 

Consultant


In accordance with the ACCME® standard for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. The following in control of content had no relevant financial relationships to disclose.

Contact

Name: 
Shelly Martin
Phone number: 
+1 (414) 955-3106